
Opinion|Videos|October 7, 2024
Current Treatment Options for Dravet Syndrome
Author(s)M. Scott Perry, MD
Key Takeaways
- The primary treatment goal for Dravet syndrome is reducing seizure frequency and severity while improving quality of life and minimizing side effects.
- Initial treatments for Dravet syndrome include valproate and clobazam, which are effective in managing seizures.
The panelist discusses how the goal of Dravet syndrome treatment is to reduce seizure frequency and severity, typically starting with initial treatments like valproate and clobazam and potentially escalating to combination therapies including options such as cannabidiol, with the overall aim of improving patients’ quality of life and developmental outcomes
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is the goal of treatment for Dravet syndrome?
- Please describe the recommended initial treatments for Dravet syndrome.
- Valproate
- Clobazam
- Please describe the recommended initial treatments for Dravet syndrome.
- Please describe treatment options that are available as escalation therapy in combination with initial treatments for Dravet syndrome.
- Stiripentol
- Cannabidiol
- Fenfluramine
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Subcutaneous Efgartigimod Shows Efficacy in Phase 2 ALKIVIA, Phase 3 ADAPT SERON Trials
2
Open-Label Extension Highlights Continued Therapeutic Benefit of Nipocalimab in Patients Transitioning From Placebo
3
B-Cell Modulator Obexelimab Shows Pronounced Relapse Reduction in Phase 2 MoonStone Trial
4
Independent Adjudication Committee Helps Facilitate Accurate Enrollment of Phase 2/3 ARISE Trial of Nipocalimab
5









































